Market revenue in 2023 | USD 4.5 million |
Market revenue in 2030 | USD 15.5 million |
Growth rate | 19.2% (CAGR from 2023 to 2030) |
Largest segment | Cell & gene therapy |
Fastest growing segment | Cell & Gene Therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cell & Gene Therapy, Immunotherapy |
Key market players worldwide | Charles River Laboratories International Inc, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Lonza Group Ltd, Viva Biotech, VGXI, PlasmidFactory, BioCina, TriLink BioTechnologies, Esco Aster |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna contract manufacturing market will help companies and investors design strategic landscapes.
Cell & gene therapy was the largest segment with a revenue share of 60% in 2023. Horizon Databook has segmented the Thailand plasmid dna contract manufacturing market based on cell & gene therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Government spending on health has rapidly increased from less than 50.0% in 1995 to almost 80% in 2020. In addition, Thailand's population is aging, and the proportion of people over 60 is one of the largest in the ASEAN region when compared to other nations.
Furthermore, it is anticipated that by 2045, this share would exceed that of other regions, including Europe and the U.S. Thailand is focused on conducting clinical research in accordance with the guidelines established by the International Conference on Harmonization-Good Clinical Practice (ICH-GCP).
There is a definite possibility for continuous expansion in R&D in Thailand due to the organizations and research institutes that promote creation & testing of medicines and technical innovations. Hence, the abovementioned factors would propel growth of the plasmid DNA contract manufacturing market in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand plasmid dna contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Thailand plasmid dna contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account